This study evaluates anticoagulants' effects on blood cell counts and immune functions in rainbow trout, indicating Li-Heparin preserves leukocyte activity better.
Hematological and immunological parameters may be influenced by various factors, including anticoagulants used to collect blood samples. This study aimed to evaluate the effect of three different anticoagulants (Li-Heparin, K3EDTA, and ACD-A) on rainbow trout blood cell count and morphology, leukocyte viability, ROS production, and phagocytosis. These evaluations were assessed through a combined approach based on flow cytometry and microscopy. Blood cell counts revealed differences in erythrocyte and thrombocyte count between anticoagulants (p < 0.001 and p < 0.01, respectively). Whole-blood samples collected in Li-Heparin displayed no hemolysis, in contrast to ACD-A and K3EDTA. A lower percentage of live cells and a higher percentage of apoptotic and dead cells were observed in K3EDTA compared to ACD-A (p < 0.05). Significantly lower ROS levels were observed in myeloid cells in Li-Heparin and ACD-A, compared to K3EDTA samples (p < 0.05). Overall, Li-Heparin better preserves rainbow trout blood cells in terms of hematological count, cell morphology, and ROS production and does not negatively affect the phagocytosis ability of leukocytes. Furthermore, the combined use of both flow cytometry and microscopy can provide a deeper insight into morpho-functional characteristics of leukocytes. Finally, we propose a flow cytometric assay to evaluate rainbow trout leukocyte viability, ROS production, and phagocytosis.
No takes yet. Share an insight, caveat, or question.
Iorio et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: